Greenstone Llc Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Class II · Ongoing
May 5, 2019
Zydus Pharmaceuticals USA Inc CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II · Terminated
Oct 9, 2014
American Health PAckaging Subpotent; 6 month stability time point
Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).